Answers are grounded in this paper and cite their sources.
Narrative review highlights the complexities of diagnosing autoimmune hepatitis and identifies contributing risk factors.
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease of unclear etiology, characterized by loss of immune tolerance to hepatocyte antigens in genetically predisposed individuals. Despite global occurrence and increasing prevalence, no uniform pattern of environmental triggers or genetic susceptibility has been established. Clinically, AIH demonstrates marked heterogeneity, ranging from asymptomatic biochemical abnormalities to acute liver failure or advanced cirrhosis at presentation, posing significant diagnostic challenges. Diagnosis relies on a combination of serological, biochemical, and histopathological findings. Although autoantibodies and elevated immunoglobulin G levels remain key diagnostic markers, their limited specificity and occasional absence—particularly in acute presentations—complicate clinical assessment. Liver biopsy continues to play a central role in diagnosis, disease staging, and therapeutic decision-making, despite the growing availability of noninvasive methods. Histopathological features such as interface hepatitis, plasma cell infiltration, and lobular inflammation support the diagnosis but are not pathognomonic. The pathogenesis of AIH involves complex immune dysregulation, including T-cell–mediated responses, impaired regulatory mechanisms, and aberrant antigen presentation. Emerging evidence highlights the potential contribution of intestinal barrier dysfunction and gut microbiota alterations to disease development and progression, although the underlying mechanisms remain incompletely understood. Genetic predisposition, particularly within the HLA region, along with female sex and age-related factors, contribute to disease susceptibility. Additionally, AIH may coexist with other autoimmune conditions, further complicating its clinical course and diagnosis. In summary, AIH remains a diagnostically challenging and clinically diverse disease requiring a multidisciplinary approach. Advances in immunology, histopathology, and microbiome research may improve understanding of disease mechanisms and facilitate the development of more precise diagnostic and therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Góral et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: